Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-12-30 4:37 pm Purchase |
2021-12-29 | 13G | Keros Therapeutics, Inc. KROS |
Deep Track Capital, LP | 1,288,724 5.450% |
1,288,724 (New Position) |
Filing History |
| 2021-02-16 4:00 pm Purchase |
2020-12-31 | 13G | Keros Therapeutics, Inc. KROS |
Logos Global Master Fund LP | 450,000 1.900% |
450,000 (New Position) |
Filing History |
| 2021-02-16 10:56 am Sale |
2020-12-31 | 13G | Keros Therapeutics, Inc. KROS |
Foresite Capital Fund IV, L.P. | 1,412,705 6.100% |
-15,366 (-1.08%) |
Filing History |
| 2021-02-10 4:48 pm Sale |
2021-01-31 | 13G | Keros Therapeutics, Inc. KROS |
RA Capital Management, L.P. | 0 0.000% |
-1,875,000 (Position Closed) |
Filing History |
| 2021-02-10 4:31 pm Purchase |
2020-12-31 | 13G | Keros Therapeutics, Inc. KROS |
RA Capital Management, L.P. | 1,875,000 8.100% |
1,875,000 (New Position) |
Filing History |
| 2021-02-08 10:25 am Sale |
2021-02-05 | 13G | Keros Therapeutics, Inc. KROS |
FMR LLC | 2,644,620 11.411% |
-381,261 (-12.60%) |
Filing History |
| 2021-02-02 3:13 pm Purchase |
2020-12-31 | 13G | Keros Therapeutics, Inc. KROS |
BlackRock Inc. BLK |
1,199,201 5.200% |
1,199,201 (New Position) |
Filing History |
| 2020-12-17 06:48 am Unchanged |
2020-12-17 | 13D | Keros Therapeutics, Inc. KROS |
Moshe Arkin | 2,036,140 8.790% |
0 (Unchanged) |
Filing History |
| 2020-11-25 06:31 am Unchanged |
2020-11-17 | 13D | Keros Therapeutics, Inc. KROS |
Moshe Arkin | 2,036,140 8.790% |
0 (Unchanged) |
Filing History |
| 2020-11-20 4:32 pm Unchanged |
2020-11-19 | 13D | Keros Therapeutics, Inc. KROS |
ORBIMED ADVISORS LLC | 1,268,734 5.500% |
0 (Unchanged) |
Filing History |
| 2020-11-10 10:27 am Purchase |
2020-11-09 | 13G | Keros Therapeutics, Inc. KROS |
FMR LLC | 3,025,881 14.999% |
3,025,881 (New Position) |
Filing History |
| 2020-08-31 1:35 pm Purchase |
2020-08-20 | 13G | Keros Therapeutics, Inc. KROS |
Logos Global Management LP | 1,350,000 6.700% |
1,350,000 (New Position) |
Filing History |